Literature DB >> 32437060

Health-related quality of life among siblings of kidney transplant recipients.

Jenny Velasco1, Jorge Roberto Ferraris1, Alfredo Eymann2, Lidia Florinda Rosa Ghezzi1, Paula A Coccia1, Verónica Ferraris1.   

Abstract

Studies are increasingly recognizing health-related quality of life (HRQOL) as a key pediatric outcome in both clinical and research settings and an essential health outcome measure to assess the effectiveness of medical treatment. However, it has not yet been studied among the healthy siblings of kidney transplant recipients. The aim of this study, therefore, is to examine HRQOL among this population. We asked the following three groups to complete a validated measure of HRQOL among children (KIDSCREEN-52): siblings of children who had received kidney transplants (n = 50), kidney transplant recipients (n = 43), and a healthy control group (n = 84). We found that siblings of kidney transplant patients exhibited lower scores for financial resources and autonomy than kidney transplant recipients. They also served lower on physical well-being, financial resources, autonomy, and parent relations/home life than the control group. However, they scored higher on social acceptance than kidney transplant recipients. Our study underscores the importance of assessing HRQOL in families including a child diagnosed with a chronic illness. Siblings require social and psychological support to promote coping and adaptation.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  chronic disease; health-related quality of life; kidney transplant recipients; siblings

Mesh:

Year:  2020        PMID: 32437060     DOI: 10.1111/petr.13734

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  1 in total

Review 1.  A scoping review of the experiences and well-being of siblings of children with chronic kidney disease: implications for practice and research.

Authors:  Caroline Piotrowski; Ashley Giesbrecht; Aviva Goldberg; Danielle Judd; Regina Rempel; Julie Strong; Melissa Weavers
Journal:  Pediatr Nephrol       Date:  2022-05-04       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.